80 results
Page 2 of 4
F-3
EX-4.1
yibm2npjk5 xp
17 Feb 22
Shelf registration (foreign)
4:14pm
6-K
o9uqyscbpyw9hxp21hi3
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
6-K
EX-99.3
flvnjev7jk9tfsw1ga
28 Jan 22
ObsEva Announces Corporate Updates
5:16pm
6-K
EX-99.2
c5tul5
4 Nov 21
Index to Unaudited Condensed Consolidated Financial Statements
7:21am
6-K
EX-99.1
1ivdxk
4 Nov 21
Index to Unaudited Condensed Consolidated Financial Statements
7:21am
6-K/A
EX-99.2
iuzbn4 70g6p2hk
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
vd0p3cv z3
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.2
uh5w2 n2r
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.2
gt75y5f e4pbrup8qy
5 Aug 21
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.1
81q7 3r7hz2w
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.2
ywoeliqqbsjy4l996
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
uwdv3andoi7 e2ap6ato
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-1.1
jxh5347en 6pxrq6fd
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
424B5
739z5cm o70igx7hy9
8 Sep 20
Prospectus supplement for primary offering
7:31am
6-K
EX-99.2
hfz8vziw1los cp
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.1
qx3sdwkh
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am